AIM
ARK Investment Management’s 10x Genomics TXG Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $161M | Buy |
13,892,103
+1,046,390
| +8% | +$12.1M | 1.18% | 23 |
|
|
2025
Q1 | $112M | Buy |
12,845,713
+901,656
| +8% | +$7.87M | 1.12% | 27 |
|
|
2024
Q4 | $172M | Buy |
11,944,057
+1,193,712
| +11% | +$17.1M | 1.43% | 21 |
|
|
2024
Q3 | $243M | Buy |
10,750,345
+1,436,582
| +15% | +$32.4M | 2.22% | 12 |
|
|
2024
Q2 | $181M | Buy |
9,313,763
+3,029,951
| +48% | +$58.9M | 1.61% | 21 |
|
|
2024
Q1 | $236M | Buy |
6,283,812
+2,242,525
| +55% | +$84.2M | 1.63% | 19 |
|
|
2023
Q4 | $226M | Buy |
4,041,287
+1,047,827
| +35% | +$58.6M | 1.34% | 22 |
|
|
2023
Q3 | $123M | Sell |
2,993,460
-120,089
| -4% | -$4.95M | 0.94% | 25 |
|
|
2023
Q2 | $174M | Sell |
3,113,549
-1,041,774
| -25% | -$58.2M | 1.15% | 23 |
|
|
2023
Q1 | $232M | Sell |
4,155,323
-161,244
| -4% | -$9M | 1.59% | 20 |
|
|
2022
Q4 | $157M | Sell |
4,316,567
-260,247
| -6% | -$9.48M | 1.36% | 23 |
|
|
2022
Q3 | $130M | Buy |
4,576,814
+973,528
| +27% | +$27.7M | 0.91% | 26 |
|
|
2022
Q2 | $184M | Buy |
3,603,286
+211,948
| +6% | +$10.8M | 1.09% | 24 |
|
|
2022
Q1 | $258M | Buy |
3,391,338
+730,472
| +27% | +$55.6M | 1.08% | 25 |
|
|
2021
Q4 | $396M | Sell |
2,660,866
-441,085
| -14% | -$65.7M | 1.2% | 25 |
|
|
2021
Q3 | $452M | Sell |
3,101,951
-1,198,086
| -28% | -$174M | 1.08% | 25 |
|
|
2021
Q2 | $842M | Buy |
4,300,037
+795,916
| +23% | +$156M | 1.57% | 16 |
|
|
2021
Q1 | $634M | Buy |
3,504,121
+2,970,625
| +557% | +$538M | 1.26% | 21 |
|
|
2020
Q4 | $75.5M | Buy |
533,496
+302,399
| +131% | +$42.8M | 0.2% | 83 |
|
|
2020
Q3 | $28.8M | Sell |
231,097
-105,456
| -31% | -$13.1M | 0.17% | 69 |
|
|
2020
Q2 | $30.1M | Buy |
+336,553
| New | +$30.1M | 0.32% | 49 |
|